The global pet tick and flea prevention market size is calculated at USD 9,727 million in 2024 and is predicted to reach around USD 14,962 million by 2034, expanding at a CAGR of 4.4% from 2024 to 2034.
The pet tick and flea prevention market is a highly specialized part of the pet care niche, mainly focused on pest management and control affecting dogs and cats. The tablets are systemic treatments that are administered to the pets by their owners, in the form of chewable biscuits or pellets. They are effective for a longer duration, often providing protection from fleas and ticks for an extended period.
The growth rate of the market is high due to the increasing number of flea and tick infections in pets. The growing pet population with increasing spending on the healthcare needs of the pet advances the need for flea and tick medications. Further, advancements in formulation technologies including new types of active substances and combination products offer improved efficacy and safety to address the disease leading to the general growth of this pet tick and flea prevention market.
According to the North American Pet Health Insurance Association, or NAPHIA, there was a 20.9-percent increase in the year-on-year growth of pet insurance for the year 2023; at the end of the year 2023, 6.25 million pets in North America had insurance compared with 5.17 million insured pets in the year 2022. Therefore, an increase in the number of pet insurance available in the region should mean that the rate of treatment adoption in the market will also be high.